CML is a slow developing type of blood cancer which affects the white blood cells known as myeloid cells.ÌýÌý
CML has three phases, and most people are diagnosed during the first phase, known as the chronic phase. Some individuals are diagnosed during the high-risk chronic phase (also called the accelerated phase) or the blast phase.Ìý
Ìý
Chronic phase
Most people (around 9 in 10) are diagnosed with CML during the chronic phase, which is the earliest and slowest progressing stage. This phase may be detected through a routine blood test, and the number of immature myeloid blasts in the blood and bone marrow remains low. Some individuals may start feeling unwell, but many experience mild symptoms or none at all.
Ìý
High-risk chronic phase (or accelerated phase)
If CML is left untreated, it can progress more quickly into the high-risk chronic phase, also known as the accelerated phase. During this phase, the number of immature myeloid blast cells in the blood and bone marrow increases, occupying space that should be filled with healthy blood cells. As a result, symptoms tend to become more noticeable.
Ìý
Blast phase
The blast phase, also known as the acute phase or blast crisis, is an excess of immature myeloid blasts in the blood and bone marrow, leading to a shortage of mature, healthy blood cells. Symptoms become more severe during this phase. The blast phase is similar to acute leukaemia, and some people may develop and transform into acute myeloid leukaemia (AML) or acute lymphoblastic leukaemia (ALL).
More information can be found here: